Scheiter, A.; Keil, F.; Lüke, F.; Grosse, J.; Verloh, N.; Opitz, S.; Schlosser, S.; Kandulski, A.; Pukrop, T.; Dietmaier, W.;
et al. Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy. Curr. Oncol. 2021, 28, 1161-1169.
https://doi.org/10.3390/curroncol28020112
AMA Style
Scheiter A, Keil F, Lüke F, Grosse J, Verloh N, Opitz S, Schlosser S, Kandulski A, Pukrop T, Dietmaier W,
et al. Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy. Current Oncology. 2021; 28(2):1161-1169.
https://doi.org/10.3390/curroncol28020112
Chicago/Turabian Style
Scheiter, Alexander, Felix Keil, Florian Lüke, Jirka Grosse, Niklas Verloh, Sabine Opitz, Sophie Schlosser, Arne Kandulski, Tobias Pukrop, Wolfgang Dietmaier,
and et al. 2021. "Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy" Current Oncology 28, no. 2: 1161-1169.
https://doi.org/10.3390/curroncol28020112
APA Style
Scheiter, A., Keil, F., Lüke, F., Grosse, J., Verloh, N., Opitz, S., Schlosser, S., Kandulski, A., Pukrop, T., Dietmaier, W., Evert, M., Calvisi, D. F., & Utpatel, K.
(2021). Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy. Current Oncology, 28(2), 1161-1169.
https://doi.org/10.3390/curroncol28020112
